Company Avisa Diagnostics Inc. Canadian Securities Exchange
Equities
MKU.H
CA05380J1075
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Consulting
95.8
%
| 1 | 93.8 % | 0 | 95.8 % | -65.79% |
Support and Maintenance
4.2
%
| 0 | 2.1 % | 0 | 4.2 % | -33.90% |
Sales per region
CAD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -66.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 21-04-19 | |
Director of Finance/CFO | 58 | 21-06-21 | |
Barbara Bunger
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-01 |
Richard Murray
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 21-04-19 | |
Brian Birk
BRD | Director/Board Member | 64 | 21-04-19 |
Rajeev Dewan
BRD | Director/Board Member | 51 | 21-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,935,784 | 58,935,784 ( 100.00 %) | 0 | 100.00 % |
Company contact information
![address Avisa Diagnostics Inc.(MKU.H)](https://cdn.zonebourse.com/static/address/43536361.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |